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Abstract
Self-inspection is a requirement of most Quality Management Systems. Within an
organisation, it is a key process for self-assessing compliance to regulatory requirements.
Done well, it can be a very informative system – highlighting gaps and driving improvement.
However, these audits can vary in effectiveness and the contribution of the programme can
be difficult to assess and measure. Ensuring that there is an effective system in place is
challenging.
This paper assesses how the effectiveness of self-inspection programmes is currently
measured and reviews the expectations of quality system regulations and standards. Based
on this research, a Self-Inspection Programme Effectiveness Assessment (SI-PEA) tool was
developed. SI-PEA is a risk-based method for assessing effectiveness of the self-inspection
programme, verifying compliance to current quality system regulations, and identifying if
there are opportunities to improve the programme. The tool ultimately assigns a risk score to
the programme’s overall effectiveness. The tool was developed for application in a
pharmaceutical quality system but is suitable for application within any quality management
system. The developed SI-PEA tool has been successfully piloted across two companies to
prove its functionality.

Introduction
In the European Union (EU), self-inspection is a requirement of a pharmaceutical quality
system and is used to monitor the application of Good Manufacturing Practice (GMP) [1]
through the Quality Management System (QMS). Specifically, the requirement is that ‘There
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is a process for self-inspection and/or quality audit1, which regularly appraises the
effectiveness and applicability of the Pharmaceutical Quality System’
The objective of self-inspection is to monitor the company’s compliance with GMP
requirements, identify gaps, and implement change as required. The self-inspection
programme is also a mechanism to highlight areas of continuous improvement within the
QMS. The International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use (ICH) in their Q10 Guidance: Pharmaceutical Quality System
[2] recommends using self-inspection as one performance indicator of the effectiveness of a quality system and
as a means of identifying innovations that might enhance the quality system. The challenge is to understand
how well the programme achieves these objectives.

This research created a method or tool to measure the effectiveness of a self-inspection
programme using a risk-based approach. This tool both assesses the performance of the selfinspection programme and identifies opportunities for improvement, aligning with the intent
of ICH Q10. A risk score is assigned based on the assessment criteria and this score is then
used to track improvements to the programme, thereby demonstrating improvement.
There were four stages and methods utilised in this research:
1. A Literature Review was performed to summarise the expectations of a self-inspection
programme across several quality system standards. This was supplemented with a review
of publications specifically discussing the effectiveness of self-inspection
2. A survey was conducted with quality specialists within the pharmaceutical industry to
understand the current approaches to monitoring and improving self-inspection
programmes

3. An interview was conducted with a representative of a regulatory authority – and
published expert on this topic -to understand expectations
4. The tool was developed and piloted across two companies. The output was analysed and
determined to be informative and useful.

1

Throughout the documents reviewed for this paper, the term self-inspection is interchangeable with the term
internal audit. The meaning of both terms is the same and therefore no differentiation will be made throughout
this paper.
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Literature Review
Self-Inspection is a requirement of many quality system standards and regulations. The
standards selected for this review apply to the pharmaceutical industry or related sectors,
such as the medical device sector. These references were used to develop a matrix of
requirements (TABLE 1). The intent in analysing these requirements was to assure that all the
requirements were captured in any subsequent assessment process.
It was noted that, while there is a requirement to perform internal audits in the US Food and
Drug Administration (FDA) quality system requirements for medical devices 21 CFR 820 [3],
there is no requirement in the US pharmaceutical regulation 21 CFR 210/211 [4]. However,
FDA have contributed to and endorsed ICH Q10 which, as discussed previously, recommends
self-inspection as a key element in QMS performance review. Therefore both 21 CFR 820 and
ICH Q10 were reviewed in detail for self-inspection requirements
In addition, FDA are a member of the Pharmaceutical Inspection Co-Operation Scheme
(PIC/S). The PIC/S recommendation on QMS requirements for Pharmaceutical Inspectorates
[5] advises on the assessment of Internal Audit within a QMS under inspection. Therefore,
this was included also.

3
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Key: X = Requirement referenced / Grey = No requirement
Key Highlighted
Requirement

EudraLex
[1]

21 CFR
820.22 [3]

ICH Q10
[2]

ISO 9001 [6]/
ISO 13485 [7]

ISO 19011
[8]

GVP
[9]

PIC/S
[5]

X

X

X

X

X

X

Details within procedure

X

X

X

Risk Based approach to
planning (frequency)

X

X

X

X

Risk factors defined

X

X

X

X

X

X

X

X

X

X

X

X2

Procedure in Place

Auditor competency

X

X

Auditor competency
details

X
X

Records of Findings

X

X

X

X

X

X

X

Use of CAPAs

X

X

X

X

X

X

X

Incorporated root cause
and impact analysis
Records review by
Management
Specific reference to
audit area management

X
X

Re-audit

X

X

X

Audit programme
evaluation

X

X

X

X

X

X

X

X

X

X

X

Table 1: Summary of Review of Regulations, Standards & Guidance

The quality standards of the International Standards Organisation (ISO) were also included in
the review. The review included both the current version of the general quality standard, ISO
9001:2015 Quality Management Systems [6] and the specific requirements for the Medical
Device industry – ISO 13485:2016 [7]. The ISO suite of standards also has a specific standard
for the application of internal audit – ISO 19011:2018 Guidelines for Auditing Management
Systems [8]. This standard details expectations in relation to internal audit and is referenced
in the PIC/s document previously mentioned and was, therefore, included in this review.
Both the EU GMP Requirements – Eudralex Volume 4 [1] (specifically Chapters 1 and 9) as
well as those documented in the Good Vigilance Guidance [9] were included. Although GVP
guidances do not form part of the EU GMP requirements, they contain much more detailed
recommendations on self-inspections and therefore were included in this review.

2

Cross Reference to ISO 19011
4
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The outcome of this analysis is summarised in TABLE 1. The comparison established, that
although there are many common requirements, there are some differences in expectations
and also in the level of detail.
For example, the use of a risk-based approach to the determination of frequency and duration
of self-inspection is not mentioned in either of the regulations included in the review –
Eudralex Volume 4 or 21 CFR 820. However, it is mentioned in the guidance and standards
reviewed. The usefulness of the risk-based approach has, however, been mentioned in
presentations by competent authorities [10] and may be regarded as a current expectation
of the process. By identifying those areas within the operation that are most complex or that
have indicated negative trends within the QMS e.g., monitoring of issues, change or
competence – the programme can more effectively apply its resources. This is an approach
taken by the authorities themselves when assessing audit frequency and duration of facilities
[11]. It is therefore included as an expected application in this work. In addition to using a risk
based approach for determining frequency and duration, Jeroncic [12] describes the use of risk based approach
as part of planning and conducting of self-inspection to ensure their effectiveness.

Another interesting example of inconsistency is the requirement for auditor impartiality and
competency. While this is a requirement described in both EudraLex Volume 4 and 21 CFR
820.22, there are no further details outlined. ISO 19011:2018 does detail these requirements
and this standard is cross- referenced in the PIC/s QMS requirements for Pharmaceutical
Inspectorates. This indirect reference implies that is an expectation. The matrix of
expectations was used to inform the developed tool. However, to assist in resolving some of
these inconsistencies in expectations, the interview with a regulatory authority
representative was included in the process.
In an interview with a regulatory authority senior GMP Inspector, O’Donnell [13] highlights
some areas within a self-inspection program that should be critically examined in order to
increase value of their self-inspection program thereby improving effectiveness. One of the
areas described is that the inspections are carried out in the right areas, in the right intervals,
and by the right personnel. Such criterion have also been identified throughout the analysis
as per TABLE 1 as well as being incorporated into the SI-PEA tool.

5
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Further literature review focused on the measurement of effectivity of the self-inspection
system. There were some informative contributions. Hanim Fraudziah et al [14] described
measuring the effectiveness of self-inspection based on a review of the self-inspection
procedures and assessing compliance with the applicable standards. However, these authors
considered that this approach represents an audit of the compliance of the audit process and
does not constitute a measure of its effectiveness.
Dittenhofer [15] approached measuring effectiveness by reviewing audit outcomes. An audit
programme was considered effective when there were no findings or when findings were
resolved. This approach is common in the pharmaceutical industry as evidenced by a survey
conducted as part of this research. However, the flaw with this approach is the inability to
determine whether a lack of audit findings is due to satisfactory implementation of the QMS
or an incompetence of the self-inspection programme with respect to identifying deficiencies.
This research concluded that this approach alone was not an adequate assurance of effective
application of the programme.
To further develop this review, the work of O’Mahony [16] was studied in detail. O’Mahony
analysed the findings of one regulatory authority – the HPRA (Health Products Regulatory
Authority of Ireland) with respect to self-inspection deficiencies identified in inspections from 20132017 (Table 2). Note this does not reflect all inspection types performed by the HPRA.

Deficiency Type

#
times
cited
14
14
11
11
11
8

Lack of/ Inadequate Procedure
Failure to apply Quality Risk Management
Lack of Management Commitment
Audit Resources/ Training
Schedule Adherence
CAPA implementation and closure
Table 2: Summary of HPRA Self-Inspection Findings 2013-2017

Of interest from this study is that compliance with the requirements, as suggested by Hanim
Fraudziah, is a performance factor that cannot be excluded from an assessment of the
programme, as it represents the most common deficiency. However, this may also be due to
a lack of clarity on the details of expectations in this area. O’Mahony concluded in her work,
that further clarity in the regulations would improve the application of the programme.
6
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It was further noted that failure to apply a risk-based approach to the programme was also a
common deficiency. This assured these authors that including the requirements of related
guidance’s and recommendations was appropriate to assure that current expectations of the
programme were part of the evaluation of its performance.

Expert Interview
The author of the previously referenced work, Denise O’Mahony, is a Pharmaceutical Assessor
at the HPRA. This interviewee was chosen based on her current role, her experience working
in a regulatory authority, and her own research work on the topic through her M.Sc.
dissertation titled ‘GMP Chapter 9 Self Inspection Programme’ [16] and related presentations
[17]. It is important to note, however, that the views expressed were personal reflections
based on research and, while offering a perspective from outside industry, the views
expressed did not represent those of the HPRA and should not be concluded as such.
The interview was conducted through email. The questions were based on the research work
of the interviewee and were designed to inform the proposed tool. When asked about key
identifiers of effectiveness for a self-inspection programme the interviewee highlighted the
importance of both overall programme structure and management commitment, while
noting the challenge in effectively measuring the latter. This was considered when designing
the assessment tool and an assessment of management involvement was included.
The interviewee was also asked for her views on the potential usefulness of an assessment
tool and if it would be of benefit in a regulatory inspection. She expressed a view that an
appropriate tool could be used to demonstrate the effectiveness of Self Inspection within the
PQS. She noted the importance of being able to demonstrate the effectiveness of the
pharmaceutical quality system, a key requirement in availing of any regulatory relief. This is
an opinion echoed by her HPRA colleague - O'Donnell [10] who has stated that, ‘A key to
(regulatory) relief is demonstrating the effectiveness of the Pharmaceutical Quality System, as
outlined in the ICH Q10 annex’. Consequently, the proposed tool uses a risk-based approach
and incorporates the principles of ICH Q9: Quality Risk Management [18] and Q10.

7
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The interviewee was also asked her opinion on whether informal tools or independent checks,
such as walkabouts, mini audits, or checklists, might be useful to supplement the formal
audits of a self-inspection programme. The interviewee did not have a definitive view and
highlighted that this could depend on the process in question. To this point, the industry
survey as described in the next section, showed 40% of respondents using a combination of
tools as part of their self-inspection programme. These tools were considered particularly
effective at identifying opportunities for improvement. Continuous improvement is an
important element when demonstrating the effectiveness of the overall QMS.

Industry Research – Survey
To understand how self-inspection programmes are currently monitored and determined to
be effective, a research survey was conducted using a ‘Self-Inspection Programme
Effectiveness Questionnaire’. The survey consisted of 15 questions, designed to inform the
development of a risk-based measurement tool.
The form consisted of three sections; The first section was designed to establish the
demographic of the responders, establish the industry sector in which they worked, and the
role they had within the organisation. The second section was aimed at understanding the
responder’s general opinion towards a self-inspection programme. The third section
attempted to clarify the respondents own self-inspection programmes and process.
Section 1 – REPONSE DEMOGRAPHIC
Due to COVID-19 restrictions, Microsoft Forms was used to conduct the survey. The link was
shared through LinkedIn and by direct email. Therefore, it is difficult to evaluate the number
of respondents invited to contribute with the number of responses received. In total, 25
respondents completed the survey within 30 days of release. All respondents completed
every question, including the open free text questions.
Most of the respondents worked within the Biopharmaceutical industry (52%), a further 28%
within Pharmaceutical, and 8% in the Medical Device sector. Of the 25 user respondents, 15
worked within Quality Assurance and 6 worked in Quality Control. Two of the respondents
were heads of site and internal auditors.
8
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Section 2 – Role of Self Inspection
When asked to rate the value of a self-inspection on a scale of 1-5 (1=low /5=high) responses
ranged from 3 to 5, with an average score of 4.4. This indicates that the programme is
considered a valued element in the quality management system. Respondents were asked to
provide a free text reason for this score and the replies are summarised in Table 3.
No. Responses
8
13

Reasoning
External audit readiness / GMP compliance
Continuous Improvement opportunity / way to highlight problem areas.
Table 3: Reasons why the Self Inspection Programme is valued

It was noted that these reasons were provided by those that assigned a high value score to
the programme (4-5). Three respondents assigned a lower score of 3 to the programme,
explaining that the self-inspection programme was not applied with the same level of rigidity
as external or regulatory audits.

Figure 1: Survey summary responses

It was clear from the responses that the respondents considered the Self Inspection
programme as a valued element of the quality management system and that it was viewed
as a key tool for assuring compliance in regulatory audit. Given that it was considered such a
valued system, it was therefore interesting to determine how it was monitored by the
respondents.
9
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88% of respondents indicated that they apply a categorisation scheme to the findings of Self
Inspection. This is consistent with both ICH Q10 and ISO 19011:2018, both of which
recommend ranking findings to prioritise findings and aid in determining the scope of the
CAPA (Corrective and Preventive Actions) required.
To determine if these internal audits were a robust preparation for a regulatory audit, 64%
indicated up to 25% of findings were categorised as major. This indicates that the programme
is contributing to the prevention of findings in regulatory audit. However, it reveals little
information about the overall effectiveness of the programme or of its role in continuous
improvement.

Section 3 – Monitoring Self Inspection
When asked how the effectiveness of their self-inspection programme is measured (free text),
30% indicated that it was not measured. Considering how valued the system was rated, this
appeared to be high. Of those that did measure the system, 55% indicated that the evaluation
was based on the number of CAPA’s raised, their timely closure, and lack of re-occurrence of
the issue. When asked, the respondents indicated that these were also the criteria used to
evaluate the programme in Management Review3.

How is the Effectiveness of the Self Inspection
Programme Measured?

Not Measured

3

Compared to External Audit Findings

Review of CAPA Closure

Management Review, a periodic evaluation of the QMS, is also a requirement of many quality standards.
10
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This is significant to this research as it provided evidence that, despite being a means of
monitoring the QMS, the programme itself does not have a comprehensive measurement or
monitoring system.
To get full value from the survey, it was decided to add some questions relating to the
application of Quality Risk Management (QRM). It was noted in the literature review that this
was a concern to regulatory inspectors and, in O’ Mahony’s work, it was a significant reason
for regulatory citations. When asked how the frequency of self-inspections is determined,
only 68% responded with ‘based on Risk Assessment’. When surveyed for key influences in
deciding audit scope, 20% indicated that it is solely based on previous audit history. Based on
the responses, it can be deduced that between 20-30% of self-inspection programmes do not
include a risk-based approach to determining audit frequency and scope.
Responders were also asked about the level of formality applied to the self-inspection
programme and were asked about the use of formal and informal tools. The use of less formal
continuous improvement tools e.g., Gemba walks, personnel discussions, or interviews,
provide potential to reduce the number of formal audits, as suggested by Duran [19]. 52%
responded that only formal audits processes were used, while only 40% indicated that they
used a combination of informal tools and formal audits. Further questions determined that
of the 13 respondents who reported using formal audits only, 6 of them do, in fact, use
additional tools as part of their self-inspection programme, but do not see them as a means
of broadening the impact of the programme.

Development of the SI-PEA Tool
Using a template previously developed by Mulholland to apply a risk-based approach to
determining the frequency, duration, and scope of self-inspection, the authors applied the
outcomes of the above research to develop an assessment tool. It was decided to apply 10
criteria to the assessment, including those criteria already applied within all companies
surveyed i.e., adherence to schedule, number of findings, CAPA implementation, and lack of
issue re-occurrence.

11
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Based on all the considerations previously mentioned, the authors added the criteria
identified when analysing the requirements of the regulations, standards and guidance and
the most common reasons for self-inspection deficiencies in regulatory audit– compliance of
the programme and the application of QRM. Table 4 indicates the criteria used and the
justification for the application of each effectivity measurement criteria.

Figure 2: Self-Inspection Programme Effectiveness Assessment (Makarevich,2020)

If Total Rank Score >60, major improvements to internal audit
programme are required ●
If Total Rank Score >30, deficiencies in the internal audit
Control System:

programme ●
If Total Rank Score <30, areas of improvement identified for
audit programme effectiveness ●

A ranking system was developed, ranking each criterion with a score from 0 to 5, where 0
indicates good compliance and a low level of risk and 5 indicates potential area of
improvement for the self-inspection programme. Makarevich developed an excel
spreadsheet and applied a drop-down menu option to prevent values outside of this rank
rating from being selected. The overall rank was calculated across all 10 criteria. The lower
the score, the greater the performance with the system. The maximum risk score value is 90,
indicating a total lack of effectiveness. A fully effective programme, requiring no
improvement, could score the lowest risk value of Zero.
The total score obtained when assessed across all criteria gives the user an indication of the
overall effectiveness of the programme and indicates both the level of improvement required
and indicates the areas where such improvements can be made. The total rank field was also
colour coded using the traffic light system as an additional visual guide to the control system.

12
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Table 4: Criteria inclusion justification breakdown
#
1.1

Criteria
Is risk assessment
conducted for developing
the schedule?

Justification for Inclusion

1.2

Does it include factors
such as scope, time,
team.

ISO 19011:2018 5.2 specifies that each audit must be based on defined objectives, scope and
criteria.
The requirement for audit criteria, scope and frequency being defined and recorded is also
highlighted in ISO 13485:2016 8.2.4 and ISO 9001:2015 9.2

2.1

Calculate % of CAPA's
closed on time

ISO 9001:2015 and ISO13485:2016 specify the requirement for management to ensure all
corrective and correction actions are taken without any undue delay.
This is also included based on the output of the industry survey.
This criterion also aids in monitoring management commitment, as indicated by O’Mahony.
It can also identify opportunity for improvement addressing audit findings.

3.1

Is tracking performed?

ISO 19011:2018 states that implementation of the audit programme should be monitored
and measured.

4.1

Are training requirements
described in procedure?

Although all guidance reviewed discuss the competency of auditor, ISO 19011:20185
provides the additional requirement of having sector specific knowledge, completion of an
auditor training programme and having technical experience of the management system. It
also advises experience acquired under supervision of an experienced auditor.
The GVCP Guideline advises that auditors should have both education in the area and
relevant work experience

4.2

Is there evidence of
training in area under
audit? (technical
knowledge)
Is there a management
sign off on reports?

ISO 19011:2018 specifies the requirement for relevant technical knowledge of the area
under audit and, if not available, that extremal resources with the relevant knowledge
maybe used as part of an audit team.

5.2

Is the data presented at
management review?

This potential failure mode was highlighted based on the number of deficiencies found by
HPRA (O’Mahony).
Management commitment is also required by 21 CFR 820 and the ISO standards,
The requirement for management review is also outlined in ICH Q10 section 3.2.4

6.1

Description of how audit
is performed (as opposed
to how it is documented)

Both EU GMP Chapter 9 and 21 CFR 820 require a procedure to be in place.
The ISO standards define the process steps that should be included in the procedure.

6.2

Clear definitions

Clear definitions within a procedure provide a guidance to how the self-inspection
programme operates
Different approaches may be required for different audit types.

6.3

Clear instruction on steps
to be taken when
schedule not adhered to.

ISO 19011:2018 describes the need to evaluate the schedule adherence
Any deviation from the schedule may require a review to update to the initial risk
assessment performed and therefore should be documented
If a risk-based approach is applied when developing the schedule, this must be considered
when the schedule is not adhered to.

6.4

Clear timelines for raising
issues, report closure etc

Documented timelines for the self-inspection programme steps will facilitate in ensuring that
it is running smoothly and aid in schedule adherence.

5.1

The use of a risk-based approach to scheduling is highlighted in a number of standards and
guidance’s reviewed:
ISO 19011:2018 6.3.2.1 which describes using a risk-based approach to planning an audit
The GVP Guideline ‘Risk assessment should be documented for planning of audit activity’
ISO13485: 2016 Section 8.2.4 states that an audit programme plan should take into
consideration the process, the area and previous audit results.
ICH Q9 also suggests that quality risk management can be used to define frequency and
scope of audits

ISO13485:2016 8.2.4 states that management responsible for the area to be audited should
ensure the actions are taken. Area management signatures on an audit report provides
evidence for this requirement.

13
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7.1

Are there tools used
supplement to selfinspection programme,
e.g. Gemba walks, mini
area audits

Continuous monitoring tools such as the use of checklists, can facilitate the implementation
of improvements between the formal process audits. These implementations can aid in
reducing the number of findings in formal audits both as part of the programme and
external.
This can demonstrate improvement within the QMS, inform the risk assessment used to
develop the schedule, or justify reduced audit frequency within a self-inspection programme
(depending on local regulation requirements).

8.1

What is the % of findings
raised as per schedule
e.g. raising CAPA

There should be a timeframe for when findings are actioned. The adherence to the
scheduled timeline determines the output of the programme and informs the risk based
approach.

8.2

Are findings graded based
on severity i.e. Minor,
Major

The requirement for grading of findings is detailed ISO 9011 and in ICH Q10. Risk ranking is
highlighted as a potential method of audit prioritization. The grading of findings aids in
assigning timelines for finding completion and prioritising them. The grading of findings per
area can be evaluated from previous years and incorporated as part of a risk assessment
when establishing the schedule for subsequent years or evaluation frequency for audit
requirement.

8.3

Clear ownership agreed
at audit closure for
findings

The timely closure of CAPA’s is assisted if clear and appropriate ownership is assigned. This
ties in with criteria 5.1 - management approval of the final report.

9.1

Is there a review of selfinspection process?
.

EU GMP Chapter 9 requires that self-inspection itself should be examined as part of the
programme. Audit of the self-inspection programme can help identify areas of improvement
of the process and procedures

10.1

How many findings have
been classified as major
within the last year

This criterion helps evaluate the efficiency of the programme in terms of identifying process
improvements.

10.2

No. of findings from
regulatory inspection
which have been
previously recorded in an
internal audit
Is there an “Lessons
learned” meetings
following the completion
of a self-inspection
schedule?

This criterion helps evaluate if the current programme is efficient. A low score on this
criterion indicates that the findings raised as part of a self-inspection programme have been
managed well and a potentially verifies the root cause of the given finding.

10.3

As per recommendation in ISO 19011 Section 5.7 ‘reviewing and improving audit
programme’ the lessons learned from programme review should feed in as inputs towards
programme improvement. This section of the ISO standard also specifies areas that should
be reviewed. In addition, ICH Q9 guide for risk management highlights audits as a planned
event which should be risk reviewed in order to take into account new knowledge and
experience (ICH Q9)

14
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The SI-PEA Tool
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Pilot Study – Self-Inspection Programme Effectiveness Assessment (SI-PEA) Tool
The assessment tool was piloted in two companies to assess its practicality and whether it
generated information that could be helpful to the organisation in determining the
effectiveness of the programme. The study was conducted in companies who use selfinspection to assess the effectivity of the QMS. In each case the tool was assessed by the
persons responsible for the programme.
Company A acts as a supplier of laboratory equipment and reagents and as a provider of
calibration and contract testing services to the pharmaceutical industry. The QMS at Company
A is a hybrid of paper and electronic based documentation and is designed to meet the
requirements of ISO 9001:2016 and ISO 17025:2017 General Requirements for the
Competence of Testing and Calibration Laboratories [20]. Company A is audited by the Irish
National Accreditation Board (INAB) and the British Standards Institution (BSI). This company
was considered as a pilot site because it also tested the usefulness of the tool as a monitoring
tool for assessing the QMS of critical suppliers.
Company B is a contract manufacturer for both the pharmaceutical and medical device
sectors and therefore complies with the regulations of both sectors. Company B is audited by
the US FDA, HPRA, and SGS. Due to its activity as a contract manufacturer, is also has
numerous critical-to-business customer audits. This company considers findings by customers
or regulatory inspectors as a significant risk and was, therefore, also a useful pilot site.
Prior to completing the study, the participants in both companies were given background
details to each criterion as per Table 4. Each participant completed the tool during a virtual
meeting. This allowed the researcher to monitor the process in addition to answering any
queries. The results obtained from each participant were not shared with the other
participant.
The functionality of the tool was assessed based on the following criteria.
1. Successful completion of all required fields and ease of use
2. Production of a realistic and reflective effectiveness score for each company
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3. Usefulness in identifying areas of improvement / gaps in current programme is clearly
identifiable to each user.

Outcome of Pilot Study
The tool demonstrated full functionality with respect to the established criteria. With access
to the relevant information, the users took between 15-20 mins to complete the tool,
confirming ease of use. While there were some questions and clarifications, the users
expressed no difficulties. The users were able to select data from a drop-down menu under
the ‘rank’ column. Once all ranks were selected, the total rank score was calculated
automatically.
The total risk rank for Company A was 25, falling in the category of <30. This determined that
overall, the programme was satisfactory, with some opportunities for improvement. The total
rank for Company B was 28 which is also in the green risk category as per control system rank
score indicator. This was consistent with the maturity of the QMS in both operations.
However, both scores indicated opportunities for improvement. The areas of improvement
identified were as follows;
1. Scheduling - Neither company took a risk-based approach to determining the audit
schedule – a key reason for regulatory findings
2. Timely closure of CAPA’s – Both companies identified that CAPAs closure this was an area
of further improvement as indicated by the SI-PEA tool

3. Procedure – Both companies identified areas of improvement within their procedures.
Company A did not have clear descriptions of how audit is performed. Neither company
documented instructions on required steps if schedule is not adhered to.
4. Findings – Company B identified a gap with respect to clear ownership agreement of
audit findings. This potentially contributes to timely CAPA closure being below target.

5. Efficiency measurement – Both companies identified that there are no ‘lessons learned’
reviews following the completion of a self-inspection schedule.
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Each participant found the tool useful in identifying areas of improvement, it was considered
easy to use with clear instructions. When requested to suggest improvements of the tool,
both recommended incorporating a prompt, prior to giving final rank score, if a section is not
completed. This assures that this omission is not overlooked.

Conclusion
Regulatory guidance and international standards require that Self Inspections be performed
to monitor the implementation of the QMS and to identify opportunities for improvement.
The most common method of establishing whether the programme is effective has been to
monitor adherence to schedule and the output in terms of findings and the implementation
of effective CAPA actions. While these criteria are appropriate, they do not monitor the full
expectations of the programme.
This research has examined these expectations comprehensively and has developed a SelfInspection Programme Effectiveness Assessment (SI-PEA) tool to monitor all the expected
criteria of the programme’s objectives. The tool incorporates a risk score which can be used
to track improvement of the programme over time. It can also identify potential areas of
improvement within a self-inspection programme and demonstrate both effectivity and
improvement. It is easy to populate, use and interpret. The tool created should first establish
compliance to all regulatory expectations since without compliance a self-inspection program
cannot be effective. The SI-PEA too can be further customised depending on a companies
activities however this should not result in removal of the existing factors discussed in the
tool.
When used to report the effectiveness of the programme to Management Review, it could
assist in establishing the effectiveness of the pharmaceutical quality system, a key
requirement to availing of any regulatory reliefs as described in Annex 1 of ICH Q10.
The tool has further potential to monitor both maturity and effectiveness. The SI-PEA tool is
a preliminary model some further work to develop further criteria would develop the latter.
In addition, further development could also assist with monitoring the Self-Inspection
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effectiveness of a suppliers QMS or of a provider of outsourced activity. It also has the
potential to be used by regulatory inspectors.
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